SRPT vs TXO · rev $1.13B vs rev $401.0M
Sarepta Therapeutics Inc (SRPT) versus MorningStar Partners, L.P. (TXO) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
MorningStar Partners, L.P. (TXO) is a oil & gas e&p company listed on NYSE.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported TXO revenue for 2025-12-31 was $401.0M. Net income was -$21.6M. Revenue was up 41.8% from 2024-12-31 to 2025-12-31. TXO currently screens at market cap $693.8M.
SRPT currently screens at market cap $2.34B. TXO currently screens at market cap $693.8M.
Not investment advice. Open the SRPT and TXO stock pages for the full models.
Not investment advice.